Abstract:Purpose: This study was designed to improve the in vivo pharmacokinetics of long-circulating vincristine sulfate (VS)-loaded liposomes; three different long-circulating materials, chitosan, poly(ethylene glycol)-1,2-distearoyl sn-glycero-3-phosphatidylethanolamine (PEG-DSPE), and poly(ethylene glycol)-poly-lactide-co-glycolide (PEG-PLGA), were evaluated at the same coating molar ratio with the commercial product Marqibo(®) (vincristine sulfate liposome injection [VSLI]). Materials and methods: VS-loaded liposomes were prepared by a pH gradient method and were then coated with chitosan, PEG-DSPE, or PEG-PLGA. Physicochemical properties, including the morphology, particle size, zeta potential, encapsulation efficiency (EE%), pH, drug loading, and in vitro release, were determined. Preservation stability and pharmacokinetic studies were performed to compare the membrane-coated liposomes with either commercially available liposomes or the VS solution. Results: The sphere-like morphology of the vesicles was confirmed by transmission electron microscope. Increased particle size, especially for the chitosan formulation, was observed after the coating process. However, the EE% was ~99.0% with drug loading at 2.0 mg/mL, which did not change after the coating process. The coating of long-circulation materials, except for chitosan, resulted in negatively charged and stable vesicles at physiological pH. The near-zero zeta potential exhibited by the PEG-DSPE formulation leads to a longer circulation lifetime and improved absorption for VS, when compared with the PEG-PLGA formulation. Compared with the commercial product, PEG was responsible for a higher plasma VS concentration and a longer half-life. Conclusion: PEG-DSPE coating may be related to better absorption, based on the stability and a pharmacokinetic improvement in the blood circulation time.

In Vitro and in Vivo Evaluation of Mpeg-Pla Modified Liposomes Loaded Glycyrrhetinic Acid

Glycyrrhizic Acid-Phospholipid Complex: Preparation Process Optimization and Therapeutic and Pharmacokinetic Evaluation in Rats

Enhanced Distribution And Extended Elimination Of Glycyrrhetinic Acid In Mice Liver By Mpeg-Pla Modified (Mpegylated) Liposome

Study on the Preparation and in Vitro Properties of Glycyrrhetinic Acid Long-circulating Solid Lipid Nanoparticles

A Novel Glycyrrhetinic Acid-Modified Oxaliplatin Liposome for Liver-Targeting and in Vitro/vivo Evaluation.

Synthesis of a Novel Polymer Cholesterol‐poly(ethylene Glycol) 2000‐glycyrrhetinic Acid (chol‐peg‐ga) and Its Application in Brucine Liposome

Optimized Preparation of Vinpocetine Micelles and in Vivo Evaluation of Its Pharmacokinetics in Rats.

Preparation, Characterization and in Vitro Evaluation of IVM Loaded Poly(lactic-Co-Glycolic Acid) (PLGA) Microspheres

In vitro and in vivo investigation of a novel two-phase delivery system of 2-methoxyestradiol liposomes hydrogel

Preparation of Paclitaxd Liposomes Modified with Mpeg-Dspe and Its Pharmacokinetics in Rats

Preparation of Long-Circulating Lipoplexes Modified with Glycyrrhetinic Acid

Novel Polyion Complex Micelles for Liver-Targeted Delivery of Diammonium Glycyrrhizinate: in Vitro and in Vivo Characterization.

Preparation and evaluation of proliposomes formulation for enhancing the oral bioavailability of ginsenosides

Preparation, Characterization and Uptake by Primary Cultured Rat Hepatocytes of Liposomes Surface-Modified with Glycyrrhetinic Acid.

Fabrication and characterization of TPGS-modified chlorogenic acid liposomes and its bioavailability in rats

Preparation and Evaluation of a Phospholipid-Based Injectable Gel for the Long Term Delivery of Leuprolide Acetaterrh.

Optimization of Encapsulation Using Milk Polar Lipid Liposomes with S-Layer Protein and Transport Study of the ACE-Inhibitory Peptide RLSFNP

PEG-PCL Modification and Intestinal Sustained-Release of Solid Lipid Nanoparticles for Improving Oral Bioavailability of 2-Methoxyestradiol.

Preparation of Glycyrrhetinic Acid Liposomes Using Lyophilization Monophase Solution Method: Preformulation, Optimization, and In Vitro Evaluation

Repeated Administration of Hyaluronic Acid Coated Liposomes with Improved Pharmacokinetics and Reduced Immune Response

The influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate